Cardiac Tissue Engineering
The limited treatment options available for heart disease patients has lead to increased interest in the development of embryonic stem cell (ESC) therapies to replace heart muscle. The challenges of developing usable ESC therapeutic strategies are associated with the limited ability to obtain a pure...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/20071 http://dx.doi.org/10.20381/ruor-4654 |